Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

“Trump Media (NASDAQ: DJT) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, PRSO Emerge”

"Trump Media (<a href="https://markets.financialcontent.com/pennwell.industriallaser/quote?Symbol=NQ%3ADJT">NASDAQ: DJT</a>) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, PRSO Emerge"

Trump Media & Technology Group (NASDAQ: DJT), the company behind Truth Social, witnessed a sharp surge on Election Day, with shares climbing as traders bet that a second Trump presidency could reignite business prospects. The stock, often regarded as a proxy for the former president’s White House chances, has seen heavy retail interest, especially on platforms like WallStreetBets, where it topped discussions, opening the way to small cap stocks some mentioned herein. 

Trump Media & Technology (NASDAQ: DJT), the operator of Truth Social, surged on Election Day, as traders speculated that a second Trump presidency could boost its business prospects. Seen as a proxy for Trump’s potential return to the White House. Despite a 33% drop last week, DJT rose 12% on Monday and gained 16.8% today in early trading. “We are trading this like GameStop (NYSE: GME) on steroids right now,” said Jay Woods, chief capital strategist at Freedom Capital Markets, on CNBC Monday. Retail interest remains high, with DJT topping discussions on WallStreetBets, though analysts caution that its long-term metrics lack fundamental support. 

Cardiol Therapeutics Inc. (NASDAQ: CRDL) is developing CardiolRx™ positioned as a treatment for myocarditis, a serious inflammation of the heart muscle often linked to viral infections, among other health conditions. Myocarditis can lead to severe complications, including heart failure, arrhythmias, and even sudden cardiac death to people of all ages. By leveraging its expertise in developing anti-inflammatory therapies, Cardiol Therapeutics seeks to improve patient outcomes at risk of heart-related complications due to inflammation.

Avalon GloboCare (NASDAQ: ALBT) has appointed Dr. Charles Cavo to its Advisory Board to advance the marketing of KetoAir™, a handheld breathalyzer for ketosis monitoring. With expertise in obesity and metabolic health, Dr. Cavo, co-founder of Pounds Transformation, will support strategic partnerships and guide KetoAir™'s business plan. Designed for real-time metabolic insights, KetoAir™ aids weight management and conditions like diabetes by measuring adherence to ketogenic diets, aligning with the growing relevance of GLP-1-based dietary approaches. 

ZyVersa Therapeutics (Nasdaq: ZVSA) has highlighted new data showing that inhibiting the NLRP3 inflammasome can protect pancreatic islet beta cells, potentially slowing the progression from obesity to insulin resistance and type 2 diabetes. Published in the International Journal of Nanomedicine, the study demonstrated that inflammasome inhibition preserved beta cell function and improved metabolic health in an obesity mouse model. These findings support ZyVersa’s development of its Inflammasome ASC Inhibitor IC 100, intended as an add-on to incretin therapy for treating obesity-related metabolic conditions.

Peraso Inc. (NASDAQ: PRSO), a leader in wireless technology, announced agreements for the immediate exercise of certain Series B warrants, allowing the purchase of 2,246,030 shares of common stock at a reduced price of $1.30 per share. This exercise is expected to generate $2.9 million in gross proceeds, and a new strong trading market at a range reflecting the $1.30 warrant exercise price is emerging. Ladenburg Thalmann & Co. Inc. serving as the exclusive placement agent for this offering.

With continued strong retail support and ongoing market momentum, Trump Media & Technology (NASDAQ: DJT) remains a focal point for traders eyeing political trends, though experts warn about the risks tied to its fundamentals.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.